| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.063 | 6.514 | 10.733 | 10.159 | 2.510 | 2.392 | 1.552 | 0 | - | 0 |
| Total Income - EUR | 2.063 | 6.514 | 10.734 | 10.161 | 2.730 | 2.392 | 1.552 | 0 | - | 0 |
| Total Expenses - EUR | 13.216 | 19.805 | 8.095 | 21.074 | 6.111 | -4.133 | 513 | 295 | - | 89 |
| Gross Profit/Loss - EUR | -11.153 | -13.290 | 2.639 | -10.913 | -3.380 | 6.525 | 1.039 | -295 | - | -89 |
| Net Profit/Loss - EUR | -11.215 | -13.486 | 2.317 | -11.217 | -3.462 | 6.453 | 992 | -295 | - | -89 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 |
Check the financial reports for the company - Lc Medpharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 428 | 518 | 734 | 116 | 0 | 0 | 0 | 0 | - | 0 |
| Current Assets | 2.474 | 2.863 | 14.918 | 6.996 | 3.220 | 303 | 3 | 17 | - | 55 |
| Inventories | 0 | 0 | 7.093 | 0 | 0 | 0 | 0 | 0 | - | 16 |
| Receivables | 1.931 | 2.715 | 6.318 | 6.580 | 3.217 | 302 | 2 | 14 | - | 35 |
| Cash | 543 | 148 | 1.507 | 416 | 3 | 1 | 1 | 3 | - | 4 |
| Shareholders Funds | -14.952 | -28.285 | -25.489 | -36.239 | -38.999 | -31.806 | -30.109 | -30.497 | - | -30.569 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | 40 |
| Debts | 17.854 | 31.666 | 41.141 | 43.351 | 42.219 | 32.109 | 30.112 | 30.514 | - | 30.623 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Lc Medpharm Srl